000 01338 a2200409 4500
005 20250515001504.0
264 0 _c20080229
008 200802s 0 0 eng d
022 _a1465-3249
024 7 _a10.1080/14653240500241925
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLiu, Z
245 0 0 _aPotent in vivo anti-tumor activity of isolated CD62L(low) lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines.
_h[electronic resource]
260 _bCytotherapy
_c2005
300 _a353-62 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCancer Vaccines
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
650 0 4 _aDendritic Cells
_ximmunology
650 0 4 _aFemale
650 0 4 _aInterferon-gamma
_xmetabolism
650 0 4 _aL-Selectin
_xbiosynthesis
650 0 4 _aLung Neoplasms
_ximmunology
650 0 4 _aLymph Nodes
_xcytology
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Inbred C57BL
650 0 4 _aPhagocytosis
_ximmunology
650 0 4 _aT-Lymphocytes
_xcytology
700 1 _aFan, H
700 1 _aWu, Y
700 1 _aChen, B
773 0 _tCytotherapy
_gvol. 7
_gno. 4
_gp. 353-62
856 4 0 _uhttps://doi.org/10.1080/14653240500241925
_zAvailable from publisher's website
999 _c15795732
_d15795732